Comparison of early events during infection of human and chimpanzee peripheral blood mononuclear cells with HIV-1

Archives of Virology

Volumn 143, Issue 11, 1998, Pages 2065-2076

  Pischinger, K ^a   Zimmermann, K ^a   Eibl, M M ^b   Mannhalter, J W ^a  

^a BAXTER HEALTHCARE CORPORATION   (United States)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BLOOD; CHIMPANZEE; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1; MONONUCLEAR CELL; VIRUS INFECTION; VIRUS ISOLATION;

ANIMALS; CELLS, CULTURED; GENE DOSAGE; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; PAN TROGLODYTES; VIRUS ACTIVATION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; PAN (APE); PAN TROGLODYTES;

EID: 0031773419     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007050050444     Document Type: Article

References (33)

1. Boldt-Houle DM, Nigida SM Jr, Rinaldo CR Jr, Ehrlich GD (1994) The T-cell receptor Vβ repertoire in naive and immunodeficiency virus-1 (HIV-1) infected chimpanzees. J Med Primatol 23: 432-441
2. Bøyum A (1968) Isolation of mononuclear cells and granulocyles from human blood. Scand J Clin Lab Invest 21 [Suppl 97]: 77-89
3. + T cells: evidence for a soluble inhibitor. J Immunol 114: 2 966-2 967
4. Bukrinsky MI, Sharova N, McDonald TL, Pushkarskaya T, Tarpley WG, Stevenson M (1993) Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc Natl Acad Sci USA 90: 6 125-6 129
5. Bukrinsky MI, Stanwick TL, Dempsey MP, Stevenson M (1991) Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254: 423-427
6. Cao Y, Qin L, Zhang L, Safrit J, and Ho DD (1995) Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 332: 201-208
7. + cells from infected and uninfected chimpanzees. Cell Immunol 132: 246-255
8. Chaffee S, Leeds JM, Matthews TJ, Weinhold KJ, Skinner M, Bolognesi DP, Hershfield MS (1988) Phenotypic variation in the response to human immunodeficiency virus among derivatives of the CEM T and WIL-2 B cell lines. J Exp Med 168: 605-621
9. Ferrari G, Ottinger J, Place C, Nigida SM Jr, Arthur LO, Weinhold KJ (1993) The impact of HIV-1 infection on phenotypic and functional parameters of cellular immunity in chimpanzees. AIDS Res Hum Retroviruses 9: 647-656
10. Ferrari G, Place CA, Ahearne PM, Nigida SM Jr, Arthur LO, Bolognesi DP, Weinhold KJ (1994) Comparison of anti-HIV-1 ADCC reactivities in infected humans and chimpanzees. J Acq Immune Defic Syndr 7: 325-331
11. + lymphocytopenia and thrombocytopenia in a chimpanzee persistently infected with human immunodeficiency virus type 1. J Infect Dis 163: 441-447
12. Fultz PN (1993) Nonhuman primate models for AIDS. Clin Infect Dis 17 [Suppl 1]: S230-S235
13. Heeney J, Bogers W, Buijs L, Dubbes R, ten Haaft P, Koornstra W, Niphuis H, Nara P, Teeuwsen V (1996) Immune strategies utilized by lentivirus infected chimpanzees to resist progression to AIDS. Immunol Lett 51: 45-52
14. Heeney J, Jonker R, Koornstra W, Dubbes R, Niphuis H, Di Rienzo A-M, Gougeon M-L, Montagnier L (1993) The resistance of HIV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction. J Med Primatol 22: 194-200
15. Heeney JL (1996) Primate models for AIDS vaccine development. AIDS 10 [Suppl A]: S115-S122
16. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M (1995) Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373: 123-126
17. Husch B, Eibl MM, Mannhalter JW (1993) CD3, CD8 double-positive cells from HIV1-infected chimpanzees show group-specific inhibition of HIV-1 replication. AIDS Res Hum Retroviruses 9: 405-413
18. Karageorgos L, Li P, Burrell CJ (1995) Stepwise analysis of reverse transcription in a cell-to-cell human immunodeficiency virus infection model: kinetics and implications. J Gen Virol 76:1 675-1 686
19. Kestens L, Vingerhoets J, Peeters M, Vanham G, Vereecken C, Penne G, Niphuis H, van Eerd P, van der Groen G, Gigase P, Heeney J (1995) Phenotypic and functional parameters of cellular immunity in a chimpanzee with a naturally acquired simian immunodeficiency virus infection. J Infect Dis 172: 957-963
20. Nara P, Hatch W, Kessler J, Kelliher J, Carter S (1989) The biology of human immunodeficiency virus-1 IIIB infection in the chimpanzee: in vivo and in vitro correlations. J Med Primatol 18:343-355
21. Novembre FJ, Saucier M, Anderson DC, Klumpp SA, O'Neil SP, Brown II CR, Hart CE, Guenthner PC, Swenson RB, McClure HM (1997) Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1. J Virol 71: 4 086-4 091
22. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD (1996) HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:1 582-1 586
23. Piatak M, Luk K-C, Williams B, Lifson JD (1993) Quantitative polymerase chain reaction for accurate quantitation of HIV DNA and RNA species. BioTechniques 14: 70-81
24. Reed LJ, Muench H (1938) A simple method of estimating fifty percent end-points. Am J Hyg 27: 493-497
25. Schuitemaker H, Meyaard L, Kootstra NA, Dubbes R, Otto SA, Tersmette M, Heeney JL, Miedema F (1993) Lack of T cell dysfunction and programmed cell death in human immunodeficiency virus type 1-infected chimpanzees correlates with absence of monocytotropic variants. J Infect Dis 168: 1 140-1 147
26. Shibata R, Hoggan MD, Broscius C, Englund G, Theodore TS, Buckler-White A, Arthur LO, Israel Z, Schultz A, Lane HC, Martin MA (1995) Isolation and characterization of a syncytium-inducing, macrophage/T-cell line-tropic human immunodeficiency virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivo. J Virol 69: 4 453-4 462
27. Ten Haaft PJF, Cornelissen M, Goudsmit J, Koornstra WH, Dubbes R, Niphuis H, Peeters M, Thiriart C, Bruck C, and Heeney JL (1995) Virus load in chimpanzees infected with human immunodeficiency virus type 1: effect of pre-exposure vaccination. J Gen Virol 76: 1 015-1 020
28. Vesanen M, Stevens CE, Taylor PE, Rubinstein P, Saksela K (1996) Stability in controlling viral replication identifies long-term nonprogressors as a distinct subgroup among human immunodeficiency virus type 1-infected persons. J Virol 70: 9 035-9 040
29. + T lymphocytes suppresses HIV replication. Immunology 66: 628-630
30. Watanabe M, Ringler DJ, Fultz PN, MacKey JJ, Boyson JE, Levine CG, Letvin NL (1991) A chimpanzee-passaged human immunodeficiency virus isolate is cytopathic for chimpanzee cells but does not induce disease. J Virol 5: 3 344-3 348
31. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, Shaw GM (1995) Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373: 117-122
32. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, Chen ISY (1990) HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61: 213-222
33. Zimmermann K, Schögl D, Plaimauer B, Mannhaller JW (1996) Quantitative multiple competitive PCR of HIV-1 DNA in a single reaction tube. BioTechniques 21: 480-484